| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. (XLO) has 14 insiders with recent SEC Form 4 filings, including 9 buys and 10 sells. XLO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 88.5K | $673.5K | - | |
| ? | 70.0K | $532.7K | - | |
| Dir | 62.0K | $471.8K | - | |
| Other | 33.3K | $253.0K | - | |
| Dir | 31.0K | $235.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Brennan Kevin M. | SVP, Finance And Accounting | Sale+OE | 1,826 | $0.64 | $1,174.48 | -22.3% | +1166.9% | - | |
| Jan 2, 2026 | Frankenfield Christopher James | Chief Financial Officer | Sale+OE | 7,030 | $0.64 | $4,521.70 | -22.1% | +1166.9% | - | |
| Jun 17, 2025 | Shannon James Samuel | - | Buy | 70,000 | $0.69 | $48,085.00 | +155.6% | +13.0% | - | |
| Jun 16, 2025 | Russo Rene | President And CEO | Buy | 36,289 | $0.68 | $24,680.15 | +14.8% | +9.6% | - | |
| Jan 2, 2025 | Frankenfield Christopher James | Chief Financial Officer | Sale+OE | 6,954 | $0.98 | $6,840.65 | -35.9% | -31.7% | -37.2% | |
| Jan 2, 2025 | Brennan Kevin M. | SVP, Finance And Accounting | Sale+OE | 1,803 | $0.98 | $1,773.61 | -36.1% | -31.7% | -37.2% | |
| Feb 8, 2024 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Sell | 1,000 | $0.64 | $640.00 | - | +101.7% | +13.3% | |
| Jan 12, 2024 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Sell | 4,235 | $0.85 | $3,600.45 | - | +83.0% | +48.0% | |
| Dec 10, 2021 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 42,469 | $9.66 | $410,161.39 | +0.4% | -24.1% | -77.6% | |
| Oct 26, 2021 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 775,000 | $16.00 | $12,400,000.00 | +51.2% | -12.5% | -86.4% |